Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin

Folia Histochemica et Cytobiologica

Volumn 46, Issue 3, 2008, Pages 353-359

  Strapagiel, Dominik ^a   Kasztalska, Karolina ^a   Druszczyńska, Magdalena ^a   Kowalewicz Kulbat, Magdalena ^a   Vrba, Adriana ^a   Matusiak, Agnieszka ^a   Chmiela, Magdalena ^a   Rudnicka, Wiesława ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

BCG vaccine; CD14; TLR2; TLR4; Tuberculin test

Indexed keywords

ARGININE; ASPARTIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; BCG VACCINE; CD14 ANTIBODY; CD14 ANTIGEN; CYTOSINE; GLUTAMINE; GLYCINE; ISOLEUCINE; LYMPHOCYTE ANTIBODY; THREONINE; THYMINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRYPTOPHAN; TUBERCULIN; UNCLASSIFIED DRUG; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ADHERENT CELL; ADULT; ARTICLE; BCG VACCINATION; CELL DENSITY; CELL STIMULATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MACROPHAGE FUNCTION; NORMAL HUMAN; PROTEIN BLOOD LEVEL; RECEPTOR BINDING; TUBERCULIN TEST; TUBERCULOSIS; BLOOD; GENETICS; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

BACILLI (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTIGENS, CD14; BCG VACCINE; HUMANS; HYPERSENSITIVITY, DELAYED; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUBERCULIN; TUBERCULOSIS; YOUNG ADULT;

EID: 58949102002     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0044-1     Document Type: Article

References (28)

1. World Health Statistics. Ten statistical highlights in global public health. WHO web site. 2007. Available at: http://www.who.int/whosis/ whostat2007_10highlights.pdf.
2. Comstock GW. Field trials of tuberculosis vaccines: how could we have done them better? Control Clin Trials. 1994;15:247-253.
3. Franco-Paredes C, Rouphael N, del Rio C, Santos-Preciado JI. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates. Int J Infect Dis. 2006;10: 93-102.
4. Sharbaugh RJ. Administering and interpreting the PPD tuberculin skin test. 1998. Home Care Provider. 1998;3:141-143.
5. Rook GAW, Hamelmann E, Brunet LR. Mycobacteria and allergies. Immunobiology. 2007;212: 461-473.
6. Roth A, Sodemann M, Jensen H. et al. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002. Vaccine. 2005;23:3991-98.
7. Druszczyńska M, Strapagiel D, Kwiatkowska S, Kowalewicz - Kulbat M, Rózalska B, Chmiela M, Rudnicka W. Tuberculosis still posing a threat. Polymorphism of genes regulating antimycobacterial properties of macrophages. Pol J Microbiol. 2006;55:7-12.
8. Rudnicka W, Strapagiel D, Druszczyńska M. et al. CD14 in Bacteria-driven chronic pathological inflammation. Helicobacter. 2006;11:353.
9. Landmann R, Muller B, Zimmerli W. CD14, new aspects of ligand and signal diversity. Microb and Infect. 2000;2:295-304.
10. LeVan TD, Bloom JW., Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli D. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of sp protein binding and enhances transcriptional activity. J Immunol. 2001;167:5838-5844.
11. Pacheco E, Fonseca C, Montes C, Zabaleta J, Garcia LF, Arias MA. CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol Med Microbiol. 2004; 40: 207-13.
12. Kim JL, Lee CJ, Jin MS, Lee CH, Paik SG, Lee H, Lee JO. Crystal structure of CD14 and its implications for lipopolysaccharide signalling. J Biol Chem. 2005;280: 11347-11351.
13. Bochud PY, Bochud M, Telenti A, Kalandra T. Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infect Dis. 2007; 7:531-542.
14. Finberg RW, Kurt-Jones EA. CD14 - chaperone or match-maker? Immunity. 2006;24:127-129.
15. Guha M, Mackmann N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85-94.
16. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signalling in macrophages. PNAS. 1999;96: 14459-14463.
17. Schroder NWJ, Morath S, Alexander C. et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem. 2003;278: 5587-5594.
18. Ogus AC, Yoldas B, Ozdemir T. et al. The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J. 2004;23:219-223.
19. Quesiniaux VJ, Delphine MN, Torres D. et al. Toll-like receptor 2 (TLR2) dependent positive and TLR2 independent negative regulation of proinflamatory cytokines by mycobacterial lipomannans. J Immunol. 2004;172:4425-4434.
20. Chmiela M, Paziak - Domańska B, Wadstrom T. Attachment, ingestion and intracellular killing of Helicobacter pylori by human peripheral blood mononuclear leukocytes and mouse peritoneal inflammatory macrophages. FEMS Immunol Med Microbiol. 1995;10:307-316.
21. Kowalewicz-Kulbat M, Pestel J, Biet F, Locht C, Tonnel A-B, Druszczynska M, Rudnicka W. Mycobacterium bovis BCG Mycobacteria - New Application. Pol J Microbiol. 2006;55:13-17.
22. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. Association between the Asp299Gly polymorphism in the Toll-like receptor 4 and premature birth in the Finnish population. Pediatric Res. 2002;52:373-376.
23. Schroder NWJ, Hermann C, Hamann L, Gobel UB, Hartung T, Schumann RR. High frequency of polymorphism Arg753Gln of the Toll-like receptor 2 gene detected by a novel allele-specific PCR. J Mol Med. 2003;81:368-372.
24. Lamb R, Zeggini E, Thompson W, Donn R. Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Ann Rheum Dis. 2005;64:767-769.
25. Fine PEM. BCG: the challenge continues. Scand J Infect Dis. 2001; 33:243-245.
26. Brewer TF, Colditz GA. Relationship between Bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis. 1995;20: 126-135.
27. Ben-Ali M, Barbouche M-R, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diag Lab Immunol. 2004;11:625-626.
28. Kang TJ, Lee SB, Chae GT. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocytes in lepromatous leprosy. Cytokine. 2002;20:56-62.